Home » Topics » BioWorld Science

BioWorld Science
RSS

Teveten cleared for U.S. marketing

Dec. 29, 1997

SAR leading to new topoisomerase I inhibitor presented by Banyu

Dec. 29, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Otsuka's new antidiabetic agents

Dec. 29, 1997

New antiallergic agents from Dainippon Ink & Chemicals

Dec. 29, 1997

SS Pharm. patents new antifungal agents

Dec. 29, 1997

Company Profile: Sugen

Dec. 29, 1997

Enzo's HIV gene therapy nears clinical testing

Dec. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...